VISTIDE TREATMENT FOR RELAPSING CMV RETINITIS IN PATIENTS WITH AIDS

维司肽治疗复发性巨细胞病毒视网膜炎 艾滋病是一项研究，旨在：1）使静脉注射Vistide 更广泛地适用于那些不能 耐受，或尽管接受了更昔洛韦治疗仍有进展，和/或 膦甲酸，和2）收集有关安全性的额外信息， 静脉注射维司肽治疗复发性巨细胞病毒的疗效观察 艾滋病患者的视网膜炎。艾滋病患者是高危人群， CMV的再激活。CMV感染可能无症状。然而，CMV可能 发展并对肺部造成严重和潜在的致残性损伤， 胃肠道和眼睛的视网膜。

The Vistide treatment for Relapsing Cytomegalovirus Retinitis in patients with AIDS is a research study designed to: 1) make intravenous Vistide more broadly available to patients with CMV retinitis who cannot tolerate, or have progressed despite treatment with Ganciclovir and/or foscarnet, and 2) gather additional information about the safety and effectiveness of intravenous Vistide in the treatment of relapsing CMV retinitis in patients with AIDS. Patients with AIDS are at high risk for reactivation of CMV. CMV infection may be asymptomatic. However, CMV may progress and cause severe and potentially disabling damage to the lungs, gastrointestinal tract and the retina of the eye.